Exponential yeast cells were treated with 10 [micro]M AmB in the presence (white bars) or absence (black bars) of 200 mM LNAME
for 3 h.
In this study, 20 male and 20 female Wistar rats were included (10 male and 10 female animals received LNAME
associated with HS diet and 10 male and 10 female Control animals received only tap water and HS diet).
Eight weeks of treatment with the NOS inhibitor, LNAME
, in rats induced the slow-to-fast fiber-type transformation in the soleus muscle.
Effects of preincubation with: A, Vehicle (the distilled water control), B, [10.sup.-5] M L-NG-nitroarginine methyl ester (LNAME
), C, [10.sup.-2] M tetraethylammonium (TEA), D, [10.sup.-3] M 4-aminopyridine (4-AP) and E, 3.1 x [10.sup.-7] M glibenclamide.
Control ApoE-null mice had a higher degree of expression of aortic eNOS than the DKO mice; however, this failed to increase under LNAME
treatment, while it more than tripled in the DKO (Figure 4(b)).
Each time a student changes LName
or FName in the EMPLOYEES table, a new row in the PRODUCTS table will be created automatically.
The following salts and drugs were used: NaCl, Ca[Cl.sub.2], NaHP[O.sub.4], NaHC[O.sub.3], glucose (Panreac), KCl, Mg[Cl.sub.2], K[H.sub.2]P[O.sub.4] and MgS[O.sub.4] (Probus), ascorbic acid (Prolabo), phenylephrine hydrochloride, acetylcholine chloride, indomethacin, LNAME
, L-arginine, D-arginine, ODQ, dipyridamole, glibenclamide, dimethylsulfoxide, verapamil hydrochloride, sodium nitroprusside, atropine sulfate, and propranolol hydrochloride (Sigma-Aldrich).
Putative anxiety-linked effects of the nitric oxide synthase inhibitor LNAME
in three murine exploratory behavior models.
[begin strikethrough]Tuple 1: sno n position n deptno Academic[end strikethrough]StaffTuple2: snon fnamen lnamen sexn teln academic-term n teach-roomn offices[begin strikethrough]non fnamen lname
nsexn address ntel noffice[end strikethrough] , then the following are valid:
Segundo os pesquisadores, outra probabilidade da ocorrencia de menor hipertrofia do grupo LNAME
com sobrecarga seria a reducao da liberacao de insulina pela L-NAME, o que poderia interferir a hipertrofia do musculo esqueletico, uma vez que a insulina estimula o crescimento proteico e inibe o aumento da degradacao proteica durante o exercicio.
Em contraste, Noda, Yamada, Furukawa e Nabeshima (1995) evidenciaram que a aplicacao de fenciclidina em camundongos, que induz hiperlocomocao, comportamentos estereotipados, ataxia e sniffing, alem de deficiencia na coordenacao motora, nao podem ser revertidos pelos inibidores da NOS, [N.sup.G]-nitro-L-arginina metil ester (LNAME
) e 7-NI.
: WORCESTER RETIREMENT BOARD; WORCESTER CITY COUNCIL